Abstract
Abstract
Sepsis is a growing problem worldwide and associated with high mortality and morbidity. The early and accurate diagnosis and effective supportive therapy are critical for combating mortality. The aim of the study was to compare the kinetics of four biomarkers in plasma in patients admitted to ICU including sepsis and during antibiotics treatment. Methods The biomarkers evaluated were HBP (Heparin-binding protein), HNL Dimer (Human Neutrophil Lipocalin), HNL Total and PCT (Procalcitonin). Plasma was obtained at admission to ICU and during follow-up at days 2 and 3. Antibiotic treatment was started or reviewed on admission to ICU. The results were compared to SOFA and KDIGO-scores and to survival. 277 patients admitted to ICU were included of which 30% had sepsis. The other groups were categorized as miscellaneous, other medical and trauma. Results The plasma concentrations of all four biomarkers were highly elevated with the highest concentrations in sepsis patients. During the follow-up period HNL Dimer decreased already day 2 and further so day 3 (p < 0.00001) in contrast to unchanged concentrations of the other three biomarkers. HNL Total showed the strongest relationships to the clinical scores (p < 0.0001) and was by multiples regression analysis independently related to these scores. Conclusion The neutrophil specific biomarker HNL Dimer seems to be a superior means to monitor the response to antibiotic treatment in ICU patients and confirms earlier findings of a rapid decline after adequate antibiotic treatment in sepsis. HNL Total reflects epithelial cell activity in the body and is an interesting biomarker for the management of organ failure in such patients.
Publisher
Research Square Platform LLC
Reference21 articles.
1. Epidemiology and Costs of Sepsis in the United States-An Analysis Based on Timing of Diagnosis and Severity Level;Paoli CJ;Crit Care Med
2. Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR et al. Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study. Lancet 2020 Jan 18;395(10219):200 – 11.
3. Procalcitonin decrease over 72 hours in US critical care units predicts fatal outcome in sepsis patients;Schuetz P;Crit Care 2013 Jun
4. Procalcitonin kinetics after burn injury and burn surgery in septic and non-septic patients - a retrospective observational study;Cabral L;BMC Anesthesiol
5. Prospective Observational Study to Determine Kinetics of Procalcitonin in Hospitalized Children Receiving Antibiotic Therapy for Non-Critical Acute Bacterial Infections;Katz SE;Infect Dis Ther